The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Recent developments in tubulin polymerization inhibitors: An overview
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dynamic instability of microtubule growth
Mitchison, T., & Kirschner, M. (1984) · Nature · doi:10.1038/312237a0 · Cited by 3,337
Structure of the αβ tubulin dimer by electron crystallography
Nogales, E., Wolf, S. G., & Downing, K. H. (1998) · Nature · doi:10.1038/34465 · Cited by 2,076
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Organosilicon Molecules with Medicinal Applications
Franz, A. K., & Wilson, S. O. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3010114 · Cited by 1,151
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
Tracking the ends: a dynamic protein network controls the fate of microtubule tips
Akhmanova, A., & Steinmetz, M. O. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2369 · Cited by 1,047
Walker, R. A., O'Brien, E. T., Pryer, N. K., Soboeiro, M. F., Voter, W. A., Erickson, H. P., & Salmon, E. D. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.4.1437 · Cited by 980
Etoposide: four decades of development of a topoisomerase II inhibitor
Hande, K. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00228-7 · Cited by 949
Dynamics and mechanics of the microtubule plus end
Howard, J., & Hyman, A. A. (2003) · Nature · doi:10.1038/nature01600 · Cited by 747
Structural basis for the regulation of tubulin by vinblastine
Gigant, B., Wang, C., Ravelli, R. B. G., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., & Knossow, M. (2005) · Nature · doi:10.1038/nature03566 · Cited by 734
An overview of tubulin inhibitors that interact with the colchicine binding site
Lu, Y., Chen, J., Xiao, M., Li, W., & Miller, D. D. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0828-z · Cited by 709
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark, G. G., Hill, S. A., Prise, V. E., Tozer, G. M., Pettit, G. R., & Chaplin, D. J. (1997) · PubMed · Cited by 622
Klauber, N., Parangi, S., Flynn, E. A., Hamel, E., & D’Amato, R. J. (1997) · PubMed · Cited by 524
Microtubules, microtubule-interfering agents and apoptosis
Mollinedo, F., & Gajate, C. (2003) · Apoptosis · doi:10.1023/a:1025513106330 · Cited by 477
Targeting Microtubules for Cancer Chemotherapy
Zhou, J., & Giannakakou, P. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011053352569 · Cited by 468
Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy
Raymond, E., Faivre, S., & Armand, J. P. (2000) · Drugs · doi:10.2165/00003495-200060001-00002 · Cited by 398
Downing, K. H. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.89 · Cited by 382
Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry, S. L., Tien, G., Hernandez, A. H., Plubrukarn, A., & Davidson, B. S. (1999) · PubMed · Cited by 324
Understanding microtubule dynamics for improved cancer therapy
Honore, S., Pasquier, E., & Braguer, D. (2005) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5330-x · Cited by 319
Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development
Pellegrini, F., & Budman, D. R. (2005) · Cancer Investigation · doi:10.1081/cnv-200055970 · Cited by 313
Pushing and Pulling in Prokaryotic DNA Segregation
Gerdes, K., Howard, M., & Szardenings, F. (2010) · Cell · doi:10.1016/j.cell.2010.05.033 · Cited by 290
Nguyen, T. L., McGrath, C., Hermone, A. R., Burnett, J. C., Zaharevitz, D. W., Day, B. W., Wipf, P., Hamel, E., & Gussio, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050502t · Cited by 286
Kanthou, C., & Tozer, G. M. (2002) · Blood · doi:10.1182/blood.v99.6.2060 · Cited by 280
Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine
Vacca, A., Iurlaro, M., Ribatti, D., Minischetti, M., Nico, B., Ria, R., Pellegrino, A., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v94.12.4143 · Cited by 279
Vincent, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24586 · Cited by 242
Implications of treadmilling for the stability and polarity of actin and tubulin polymers in vivo.
Kirschner, M. W. (1980) · The Journal of cell biology · doi:10.1083/jcb.86.1.330 · Cited by 240
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Davis, P. D., Dougherty, G. J., Blakey, D. C., Galbraith, S. M., Tozer, G. M., Holder, A. L., Naylor, M. A., Nolan, J., Stratford, M. R. L., Chaplin, D. J., et al. (2002) · PubMed · Cited by 231
Stähblin, H. (1973) · European Journal of Cancer (1965) · doi:10.1016/s0014-2964(73)80021-0 · Cited by 183
Guanosinetriphosphatase activity of tubulin associated with microtubule assembly.
David-Pfeuty, T., Erickson, H. P., & Pantaloni, D. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5372 · Cited by 181
Microtubule Active Agents: Beyond the Taxane Frontier
Morris, P. G., & Fornier, M. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0169 · Cited by 178
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
Blakey, D. C., Westwood, F. R., Walker, M., et al. (2002) · PubMed · Cited by 176
Baguley, B. C., Holdaway, K. M., Thomsen, L. L., Zhuang, L., & Jonathan Zwi, L. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90391-p · Cited by 172
Vinca alkaloids: Anti-vascular effects in a murine tumour
Hill, S. A., Lonergan, S. J., Denekamp, J., & Chaplin, D. J. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90082-q · Cited by 168
Localization of the colchicine-binding site of tubulin.
Uppuluri, S., Knipling, L., Sackett, D. L., & Wolff, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11598 · Cited by 157
Kinesin-13s in mitosis: Key players in the spatial and temporal organization of spindle microtubules
Ems-McClung, S. C., & Walczak, C. E. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.01.016 · Cited by 154
Romagnoli, R., Baraldi, P. G., Salvador, M. K., Preti, D., Tabrizi, M. A., Brancale, A., Fu, X., Li, J., Zhang, S., Hamel, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2013979 · Cited by 142
New substituted 4H-chromenes as anticancer agents
Patil, S. A., Wang, J., Li, X. S., Chen, J., Jones, T. S., Hosni-Ahmed, A., Patil, R., Seibel, W. L., Li, W., & Miller, D. D. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.074 · Cited by 137
Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product
Kaur, G., Hollingshead, M. G., Holbeck, S. L., Schauer-Vukašinović, V., Camalier, R. F., Dömling, A. S. S., & Agarwal, S. (2006) · Biochemical Journal · doi:10.1042/bj20051735 · Cited by 132
Self-citationRegina, G. L., Bai, R., Rensen, W. M., Cesare, E. D., Coluccia, A., Piscitelli, F., Famiglini, V., Reggio, A., Nalli, M., Pelliccia, S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3013097 · Cited by 128
Hori, K., & Saito, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601261 · Cited by 123
Bijman, M. N. A., Amerongen, G. P. V. N., Laurens, N., van Hinsbergh, V. W. M., & Boven, E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0242 · Cited by 122
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent.
Micheletti, G., Poli, M., Borsotti, P., Martinelli, M., Imberti, B., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 117
Wang, G., Li, C., He, L., Lei, K., Wang, F., Pu, Y., Yang, Z., Cao, D., Ma, L., Chen, J., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.028 · Cited by 115
Twelves, C., Cortés, J., Vahdat, L. T., Wanders, J., Akerele, C., & Kaufman, P. A. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.023 · Cited by 108
Identification of a distinct class of vinblastine binding sites on microtubules
Jordan, M. A., Margolis, R. L., Himes, R. H., & Wilson, L. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90406-7 · Cited by 106
New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent
Mooberry, S. L. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00004 · Cited by 106
Seidman, R., Gitelman, I., Sagi, O., Horwitz, S. B., & Wolfson, M. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5262 · Cited by 106
Romagnoli, R., Baraldi, P. G., Salvador, M. K., Preti, D., Tabrizi, M. A., Bassetto, M., Brancale, A., Hamel, E., Castagliuolo, I., Bortolozzi, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400043d · Cited by 92
In vitro assembly and GTP hydrolysis by bacterial tubulins BtubA and BtubB
Sontag, C. A., Staley, J. T., & Erickson, H. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410027 · Cited by 87
What tubulin drugs tell us about microtubule structure and dynamics
Amos, L. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.014 · Cited by 85
Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors
Salum, L. B., Altei, W. F., Chiaradia, L. D., Cordeiro, M. N. S., Canevarolo, R. R., Melo, C. P. D. S., Winter, E., Mattei, B., Daghestani, H. N., Santos‐Silva, M. C., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.037 · Cited by 84
Margolin, K. A., Longmate, J., Synold, T. W., Gandara, D. R., Weber, J. S., Gonzalez, R. C., Johansen, M. J., Newman, R. A., Baratta, T., & Doroshow, J. H. (2001) · Investigational New Drugs · doi:10.1023/a:1010626230081 · Cited by 82
The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
Zhang, X., Zhang, J., Tong, L., Luo, Y., Su, M., Zang, Y., Li, J. X., Lu, W. P., & Chen, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.049 · Cited by 82
Andreani, A., Granaiola, M., Locatelli, A., Morigi, R., Rambaldi, M., Varoli, L., Calonghi, N., Cappadone, C., Farruggia, G., Stefanelli, C., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2012694 · Cited by 76
Tripodi, F., Pagliarin, R., Fumagalli, G., Bigi, A., Fusi, P. A., Orsini, F., Frattini, M., & Coccetti, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201344a · Cited by 75
Pharmaceutical development of anticancer agents derived from marine sources
Nuijen, B., Bouma, M., Manada, C., Jimeno, J. M., Schellens, J. H. M., Bult, A., & Beijnen, J. H. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200011000-00003 · Cited by 71
Romagnoli, R., Baraldi, P. G., Salvador, M. K., Camacho, M. E., Preti, D., Tabrizi, M. A., Bassetto, M., Brancale, A., Hamel, E., Bortolozzi, R., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.001 · Cited by 64
Phase II Study of Dolastatin-10 as First-Line Treatment for Advanced Colorectal Cancer
Saad, E. D., Kraut, E. H., Hoff, P. M., Moore, D. F., Jones, D., Pazdur, R., & Abbruzzese, J. L. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200210000-00005 · Cited by 64
Romagnoli, R., Baraldi, P. G., Salvador, M. K., Preti, D., Tabrizi, M. A., Brancale, A., Fu, X., Li, J., Zhang, S., Hamel, E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300388h · Cited by 59
2-Cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization
Zhang, N., Ayral‐Kaloustian, S., Nguyen, T., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.070 · Cited by 59
Akselsen, Ø. W., Odlo, K., Cheng, J., Maccari, G., Botta, M., & Hansen, T. V. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.010 · Cited by 56
A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
Beale, T. M., Allwood, D. M., Bender, A., Bond, P. J., Brenton, J. D., Jones, D. S., Ley, S. V., Myers, R. M., Shearman, J. W., Temple, J., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200149g · Cited by 52
Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity
Spanò, V., Montalbano, A., Carbone, A., Parrino, B., Diana, P., Cirrincione, G., Castagliuolo, I., Brun, P., Issinger, O., Tisi, S., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.014 · Cited by 51
Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites
Honoré, S., Pagano, A., GAUTHIER, G. F., Bourgarel‐Rey, V., Verdier‐Pinard, P., Civiletti, K., Kruczynski, A., & Braguer, D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0156 · Cited by 51
De, P., Baltas, M., Lamoral‐Theys, D., Bruyère, C., Robert Kiss, A., Bedos‐Belval, F., & Saffon‐Merceron, N. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.02.041 · Cited by 44
Recent Progress in Discovery and Development of Antimitotic Agents
Kiselyov, A. S., Balakin, K. V., Tkachenko, S. E., Savchuk, N., & Ivachtchenko, A. V. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007780058650 · Cited by 43
Nakamura, M., Kajita, D., Matsumoto, Y., & Hashimoto, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.046 · Cited by 41
Rubenstein, S. M., Baichwal, V. R., Beckmann, H., Clark, D. L., Frankmoelle, W. P., Roche, D., Santha, E., Schwender, S., Thoolen, M., Ye, Q., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000478d · Cited by 40
Rai, A., Surolia, A., & Panda, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044311 · Cited by 40
Chennamaneni, S., Zhong, B., Lama, R., & Su, B. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.005 · Cited by 40
Chapter 14. Antimitotic Agents
Li, Q., Sham, H. L., & Rosenberg, S. H. (1999) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60576-x · Cited by 39
Parihar, S., Kumar, A., Chaturvedi, A. K., Sachan, N. K., Luqman, S., Changkija, B., Manohar, M., Prakash, O., Chanda, D., Khan, F., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.009 · Cited by 33
Salehi, M., Amini, M., Ostad, S. N., Riazi, G. H., Assadieskandar, A., Shafiei, B., & Shafiee, A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.030 · Cited by 32
Wang, X. F., Ohkoshi, E., Wang, S. B., Hamel, E., Bastow, K. F., Morris-Natschke, S. L., Lee, K.-H., & Xie, L. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.047 · Cited by 25
Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents
Jiang, J., Sun, B., Wang, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.004 · Cited by 24
New inhibitors of tubulin polymerisation
Angerer, E. V. (1999) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.9.8.1069 · Cited by 22
Liu, J., Zheng, C., Ren, X., Zhou, F., Li, W., Zhu, J., Lv, J., & Zhou, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300596s · Cited by 22
Dalyot-Herman, N., Delgado‐López, F., Gewirtz, D. A., Gupton, J. T., & Schwartz, E. L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.093 · Cited by 17
Al‐awar, R., Corbett, T. H., Ray, J. E., Polin, L., Kennedy, J. H., Wagner, M. M. F., & Williams, D. C. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1061.3.9 · Cited by 14
Cited by
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Indole: A privileged scaffold for the design of anti-cancer agents
Wan, Y., Li, Y., Yan, C., Yan, M., & Tang, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111691 · Cited by 516
Endophytic Fungi—Alternative Sources of Cytotoxic Compounds: A Review
Uzma, F., Mohan, C. D., Hashem, A., Konappa, N. M., Rangappa, S., Kamath, P. V., Singh, B. P., Mudili, V., Gupta, V. K., Siddaiah, C. N., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00309 · Cited by 293
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
Wang, R., Hu, B., Pan, Z., Mo, C., Zhao, X., Liu, G., Hou, P., Cui, Q., Xu, Z., Wang, W., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01704-3 · Cited by 285
Trougakos, I. P., Stamatelopoulos, K., Terpos, E., Tsitsilonis, O. E., Aivalioti, E., Paraskevis, D., Kastritis, E., Pavlakis, G. N., & Dimopoulos, M. A. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00703-5 · Cited by 278
Metadata
- Authors
- Kaur, R., Kaur, G., Gill, R. K., Soni, R., & Bariwal, J.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 87
- Pages
- 89-124
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1998236197
- Cited by
- 344
- References
- 80
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.